You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》贝康医疗(02170.HK)暗盘高开46%报40元
阿思达克 02-05 16:16
根据辉立交易平台显示,下周一(8日)挂牌的贝康医疗-B(02170.HK)暗盘高开46%报40元欠承接,现造34元,较上市价27.36元,高24%,成交59万股。

苏州贝康医疗是内地辅助生殖基因检测解决方案创新平台,旗下PGT-A试剂盒是首个也是唯一获国家药监局批准三代试管婴儿基因检测试剂盒。是次来港上市共发售6,666.7万股H股,并已引入包括清池资本、奥博资本、CRF、Affin Hwang Capital、WinTwin Capital、睿远基金及常春藤资产管理7名基石投资者,合共认购2,550.25万股(设6个月禁售期);其中10%公开发售获近402倍超购,已启动回拨机制占比增至50%,认购一手中签率10%;股份以招股范围(26.36-27.36元)上限定价,料集资净额约17.17亿元,主要用作核心产品PGT-A试剂盒、PGT-M试剂盒临床试验、注册申报及商业化、开发其他产品及提升研发能力等。上市独家保荐人中信里昂证券。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account